Corporate news

Organic growth Q3 2024 (9M 2024): Revenue +2.6% (9M 2024: 2.0%), Adjusted EBITDA +3.5% (9M 2024: 3.1%)Plastics & Devices grows organically by +9.2%…

Market advances adoption of ready-to-use containersImproved operational efficiency in pharmaceutical manufacturing processesIncreased patient safety…

Gerresheimer among the top 3 % of all rated companiesOverall result increased to 76/100 pointsAward underlines consistent implementation of the…

Organic growth: revenues +1.7%, adjusted EBITDA +2.9%Plastics & Devices division with good revenue growth and significantly improved margin Guidance…

Dividend: EUR 1.25 per share after strong 2023 financial yearGradual renewal of the Supervisory Board continues: three new shareholder representatives…

Two-stage expansion of the Peachtree City, Georgia site Total investment volume of around USD 180 million More than 400 new jobs for skilled…

Strategic acquisition: Complementary product portfolio and broad footprint with production sites in Europe Gerresheimer underpins leading market…

Gerresheimer subsidiary Centor receives exclusive distribution rights for pharmacies in the U.S.  Adherence solutions enables pharmacies to…

Organic growth: Revenues +2.8%, adjusted EBITDA +5.9%    Capacity expansion in the Americas, Europe and Asia progresses according to plan  …